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The goal of this project is to develop radionuclide molecular imaging technologies using a clinical pinhole SPECT/CT scanner
to quantify changes in cardiac metabolism using the spontaneously hypertensive rat (SHR) as a model of hypertensive-related
pathophysiology. This paper quantitatively compares fatty acid metabolism in hearts of SHR and Wistar-Kyoto normal rats as a
function of age and thereby tracks physiological changes associated with the onset and progression of heart failure in the SHR
model. The fatty acid analog, 123I-labeled BMIPP, was used in longitudinal metabolic pinhole SPECT imaging studies performed
every seven months for 21 months. The uniqueness of this project is the development of techniques for estimating the blood input
function from projection data acquired by a slowly rotating camera that is imaging fast circulation and the quantiﬁcation of the
kinetics of 123I-BMIPP by ﬁtting compartmental models to the blood and tissue time-activity curves.
1.Introduction
Hypertrophic cardiomyopathy is a condition in which the
heart muscle becomes thick, forcing the heart to work harder
to pump blood. Under normal conditions the heart uses
glucose (∼30%), fatty acids (∼60%), and lactate (∼10%)
as primary energy sources, in addition to amino acids and
ketone bodies [1–3]. In the case of cardiac hypertrophy,
however, there is an increase in cardiac mass and a switch
to a reliance on glucose metabolism. To be able to detect
and interpret the early onset of this change, there is the need
to develop methodology for sensitive predictors for early
detection, prognosis and to follow the response to therapy
for hypertrophic cardiomyopathy. In clinical settings, the
abnormalities of fatty acid metabolism in hypertrophic
cardiomyopathy can be recognized by the decreased uptake
in single-photon emission computed tomography (SPECT)
images [4]. It has also been demonstrated that compartmen-
tal analysis and dynamic SPECT imaging make it possible
to detect abnormalities of fatty acid utilization earlier than
SPECT imaging, with the potential to provide an even earlier
prediction of the onset of cardiac hypertrophy [5]. There is a
need to develop technology for imaging small animal models
on clinical SPECT systems that could easily be translated to
the clinic for diagnosis and management of patients with
cardiac hypertrophy. However, the challenge is to perform
compartmental analysis of dynamic studies in small animals
with pinhole SPECT using slowly rotating gantries (slow
camera rotation with 1s per view) when the recirculation
timeintheanimalsis6–8s.Thisstudywasdesignedtofollow
the changes in fatty acid metabolism in the left ventricular
myocardium associated with the progression of hypertrophy
in the spontaneously hypertensive rat (SHR) and, in so
doing, develop methodology for data acquisition and data
processing techniques of pinhole SPECT acquired data [6–
11].Thegoalofthisprojectistodevelopradionuclidemolec-
ular imaging technologies using a clinical dual-modality
pinhole SPECT/X-ray computed tomography (CT) scanner2 International Journal of Molecular Imaging
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Figure 1: Clinical dual-detector SPECT/CT scanner with custom pinhole collimators used for quantitative dynamic imaging of fatty acid
metabolism in the rat heart.
to quantify the changes in metabolism in the heart using
the SHR as a model of hypertensive-related pathophysiology
(Figure 1).
The SHR (Okamoto and Aoki strain) has hypertension
associated with generalized dyslipidemia and insulin resis-
tance. It has been noted that the SHR model has a defective
gene (CD36) on chromosome 4 [12]. The gene in the SHR
results in a defective fatty acid enzyme (translocase), which
functionsinlong-chainfattyacidtransportintothecell.This
compromises tissue utilization of fatty acid and increases the
basal glucose metabolism and hyperinsulinemia.
Mechanisms involved in the progression of heart failure
are believed to be, in part, related to alteration in myocardial
energy metabolism [13–15]. Plasma levels of glucose, fatty
acids, and lactate determine which of these substrates are
oxidized[16].Inthefailingheart,energysubstrateutilization
changes from fatty acid oxidation to one of glycolysis
utilization [17, 18]. In the case of pressure overload, there
is an increased reliance on carbohydrate oxidation in an
attempt to maintain contractile function. The myocardial
extraction and retention of fatty acids are impaired in the
advanced stage of heart failure [19]. The fatty acid ana-
log, β-methyl-p-[123I]-iodophenyl-pentadecanoic acid (123I-
BMIPP),currentlybeingevaluatedinhumanstudiestostudy
the progression of heart failure, has been used to image
the metabolism of fatty acids [1, 20]. Imaging with 123I-
BMIPP in a canine has shown that myocardial fatty acid
oxidation begins to be inhibited and that washout of 123I-
BMIPP increases in the compensated stage of left ventricular
dysfunction.Human,canine,androdentstudiesshowthatin
late-stage heart failure there is downregulation of myocardial
fatty acid oxidation and accelerated glucose oxidation [21–
23]. The reduction in fatty acid oxidation is not caused by
changes in fatty acid availability in the blood [24]. The time
course and the molecular mechanisms for this switch in
substrate oxidation are not well understood [25, 26].
Thispaperquantitativelycomparesfattyacidmetabolism
in the hearts of SHR and Wistar-Kyoto (WKY) normal rats
as a function of age, and thereby tracks physiological changes
associated with the onset and progression of heart failure
in the SHR model. 123I-BMIPP was used in longitudinal
metabolic pinhole SPECT imaging studies performed every
seven months for 21 months. The uniqueness of this project
is the development of techniques for estimating the blood
input function from projection data acquired by a slowly-
rotating camera imaging fast circulation in a rat, and
the quantiﬁcation of the kinetics of 123I-BMIPP by ﬁtting
compartmental models to the blood input function and
tissue uptake/washout time-activity curves (TACs).
In previous work, we addressed issues associated with
reconstructing dynamic data acquired with use of a slowly-
rotating camera [27–29]. The work presented here also
addresses quantitative eﬀects of limited spatial resolution in
dynamic pinhole SPECT that result in underestimation of
the metabolic rate of 123I-BMIPP in the rat myocardium. In
particular, the partial volume eﬀect blurs activity between
the left ventricular blood pool and surrounding myocardial
tissue and decreases contrast between the blood input and
tissue uptake TACs [11, 30, 31]. Standard compartmental
modeling straightforwardly accounts for the spillover of
blood activity into tissue volumes [32]. However, accounting
for the spillover of tissue activity into blood volumes is
more problematic, and is a focus of the work presented here.
Results are presented for imaging studies performed on two
SHRs and two WKY normal rats at three ages.
This paper is organized as follows. Section 2 begins
by describing the data acquisition protocol for acquiring
dynamic 123I-BMIPP data in a rat with use of a slowly-
rotating dual-detector pinhole SPECT system. This section
then provides overviews of our multiresolution methods for
fully 3D reconstruction of a late static SPECT image (to
determine the spatial locations for the left ventricular blood
pool and myocardial tissue) and for fully 4-D reconstruction
of an early dynamic SPECT image represented by 4-D
splines that are piecewise constant in space and piecewise
quadratic in time. Section 2 concludes with details of our
fully 4-D penalized least-squares reconstruction algorithm
that uses a smooth 4-D image prior, as well as our methods
for jointly estimating the blood input function and fatty
acid metabolism from the reconstructed dynamic SPECTInternational Journal of Molecular Imaging 3
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Figure 2: Dynamic cardiac 123I-BMIPP pinhole SPECT projection data acquired by one detector head during the interval 2–36s for (a) a
WKY normal rat and (b) an SHR. These early time frames show the arrival of the injected bolus at the heart, followed by initial uptake in
the myocardium. The maximum numbers of counts in a detector bin are 10 and 12 for the WKY normal rat and SHR, respectively.
image. Section 3 presents results obtained with use of these
algorithms applied to dynamic SPECT imaging studies
performed on two SHR and two WKY normal rats when the
rats were age 7, 14, and 21 months (one SHR died before 21
months).Thepaperconcludeswithadiscussionoftheresults
and future work in Section 4.
2.MaterialsandMethods
2.1. Pinhole SPECT System Modeling and Data Acquisition.
With use of methods described in [8, 9], dynamic cardiac
pinhole SPECT projection data and pinhole geometric
calibration data were acquired with slow gantry rotation
on a dual-detector GE Millennium VG Hawkeye SPECT/CT
scanner equipped with custom tungsten pinhole collimators
having a 1.5mm by 2mm retangular aperture (Figure 1).
The NaI(Tl) crystal in each detector has an area of 540mm
by 400mm and is 9.5mm thick. At an energy of 140keV,
the intrinsic spatial resolution is 3.9mm and the energy
resolution is 9.8%.
In the geometric conﬁguration used for imaging rats
(Figure 1), the pinhole collimators magnify the center of
the ﬁeld of view by a factor of about 4.8 on the faces of
the large detectors. In a phantom study that we performed
in this conﬁguration [8, 9], the system could easily resolve
the smallest features of the micro-Jaszczak phantom, which
are 1.2mm “cold” rod sources separated by 1.2mm in
a radioactive background [33]. Collimator response was
modeledviaraytracingandexcludedtheeﬀectsofcollimator
penetration. The system model also excluded the eﬀects of
attenuation and scatter; however, we are currently studying
these eﬀects via Monte Carlo simulation in a separate
investigation [34, 35].
123I-BMIPP was obtained from Molecular Insight Phar-
maceuticals. All imaging studies were performed in accor-
dance with an Institutional Animal Care and Use Com-
mittee (IACUC) approved protocol. Rats were anesthetized
throughout the entire procedure with use of 2–2.5% isoﬂu-
rane inhalation anesthesia. A slow (10–30s) injection of
about 4mCi (150MBq) of 123I-BMIPP, via an IV catheter
placed in the tail vein, was performed shortly after the
dynamic data acquisition began. Data were acquired for
60min in 1-s time frames with an angular step of 4 degrees
per frame (Figure 2). For the biodistributions associated
with these studies, overall system sensitivity was about
2000cps/mCi (55cps/MBq). The energy of the primary
photopeak for 123I is 159keV.
2.2. Multiresolution Fully 3D Late Static SPECT Image
Reconstruction. To determine spatial locations for the left
ventricular blood pool and myocardial tissue, late data
acquired 1.5–60min after injection were summed and a
static image was reconstructed with use of a 3D version
of the penalized least-squares image reconstruction that we
describe in Section 2.4. The late static spatial distribution
of 123I-BMIPP was modeled with use of 3D multiresolution
spatial B-splines that were piecewise constant. The 3D spatial
splines were organized on a 20 × 20 × 20 3D grid that
provided uniform sampling of 3.2mm in each dimension.
Inside the volume containing the heart, a 6 × 6 × 6
neighborhood of these lower-resolution splines was replaced
by a 12 × 12 × 12 neighborhood of higher-resolution splines
that provided uniform sampling of 1.6mm.
2.3. Multiresolution Fully 4-D Early Dynamic SPECT Image
Reconstruction. Thetime-varyingspatialdistributionof 123I-
BMIPP was modeled with use of 4-D multiresolution B-
splines that were piecewise constant in space and piecewise
quadratic in time. The 4-D splines were spatially organized
ona10 ×10 ×103Dgridthatprovideduniformsamplingof
6.4mm in each dimension. Inside the volume containing the
heart, a 3 × 3 × 3 neighborhood of these lower-resolution
splines was replaced by a 12 × 12 × 12 neighborhood of
higher-resolution splines that provided uniform sampling of
1.6mm. The 4-D splines were temporally organized on a 1D
grid that provided nonuniform sampling intervals of 0–2.4,
2.4–9.4, 9.4–30, and 30–90s during the ﬁrst gantry rotation
(Figure 3).
With use of the fully 4-D algorithm for penalized least-
squares image reconstruction that we describe in Section 2.4,
B-spline TACs for the multiresolution voxels were estimated
directly from the dynamic pinhole SPECT projection data.
This yielded estimates of temporal B-spline coeﬃcients4 International Journal of Molecular Imaging
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Figure 3: Piecewise quadratic temporal B-spline basis functions
used to reconstruct dynamic data acquired during the ﬁrst gantry
rotation.
{  amn; m = 1,...,M; n = 1,...,N},w h e r eM is the number
o fs p a t i a lv o x e l sa n dN is the number of temporal B-spline
basis functions. The estimated TAC for the mth voxel is
  Am(t) =
N  
n=1
  amnVn(t),( 1 )
whereVn(t)aretemporalB-splinebasisfunctions(Figure 3).
2.4. Fully 4-D Penalized Least-Squares Reconstruction Algo-
rithm with a Smooth 4-D Image Prior. Ad y n a m i cS P E C T
projection data model that relates detected events to a 4-
D spatiotemporal B-spline representation of a time-varying
radiotracer distribution can be written as
p = Fa,( 2 )
where p is an I-element column vector of modeled dynamic
projectiondatavalues,FisanI×(MN)systemmatrix,aisan
(MN)-element column vector of B-spline coeﬃcients, and
I is the total number of projection measurements acquired
by the SPECT detectors. The system matrix F incorporates
the spline model for time variation of the radiotracer
distribution, as well as physical eﬀects such as collimator
response that aﬀect detection of gamma rays emitted by the
radiotracer distribution.
Attheoutset,theleast-squarescriteriontobeminimized,
χ2, is simply the sum of squared diﬀerences between the
measured projections, p∗, and the modeled projections
χ2 =
 
p∗ −Fa
 T 
p∗ −Fa
 
,( 3 )
where the superscript “T” denotes the matrix transpose.
Minimizing the criterion χ2 yields an estimate,   a,o fc o e ﬃ-
cients for the 4-D B-spline basis functions that represent the
time-varying radiotracer distribution
  a =
 
FTF
 −1
FTp
∗. (4)
The corresponding minimum value for the criterion χ2 is
χ2
min =
 
p
∗ −F  a
 T 
p
∗ −F  a
 
. (5)
To reduce noise, we now wish to add a penalty term
to the criterion χ2 that encourages the reconstructed image
to be smooth in both space and time. Insight into what
a reasonable penalty term might be can be obtained by
expressing χ2 in terms of its minimum value
χ2 =
 
p
∗ −Fa
 T 
p
∗ −Fa
 
=
  
p
∗ −F  a
 
−F(a −   a)
 T  
p
∗ −F  a
 
−F(a −   a)
 
= χ2
min −2
 
p∗ −F  a
 TF(a −   a)+(a −   a)
TFTF(a −   a)
= χ2
min +(a −   a)
TFTF(a −   a).
(6)
Note that the term that is linear with respect to (a −   a)
vanishes because the model error p∗ − F  a lies in the null
space of the backprojection operator FT. Inspecting (6), one
sees that diﬀerences from the least-squares solution   a are
penalized by the term (a −   a)
TFTF(a −   a).
To mimic this eﬀect for purposes of reducing noise,
we propose to add a penalty term that resembles (a −
α)
TFTF(a−α),whereαisasmooth4-Dimagepriorobtained
by normalizing a simple backprojection of the measured
projections
α =
 
FTp∗
 
· /
 
FTF[1]
 
,( 7 )
where the operator “·/” denotes pointwise division of
elements in the left operand by the corresponding elements
in the right operand and “[1]” denotes an (MN)-element
column vector of ones. Note that normalization by FTF[1]
ensures that backprojecting the noiseless projections of a
constant image yields the original constant image. Note also
that the image prior α has the desirable physiologic property
of being nonnegative—thus, the reconstructed image is
encouraged to have nonnegative 4-D B-spline coeﬃcients.
The penalty term that we propose to use is
I  
i=1
M  
m=1
N  
n=1
 
Fmn
i (amn −αmn)
 2,( 8 )
where Fmn
i is the [i,m +( n − 1)M]th element of the system
matrix F, amn is the [m +( n − 1)M]th element of the spline
coeﬃcient vector a,a n dαmn is the [m+(n−1)M]th element
of the smooth image prior α. For the resulting negatively
correlated, zero-mean elements in the vector (a − α), (8)
imposes a penalty that is greater than the penalty imposed
by (a − α)
TFTF(a − α), and is more eﬀective at suppressing
“checkerboard” noise patterns. Note that the latter penalty
can be expressed in summation notation as
I  
i=1
⎡
⎣
M  
m=1
N  
n=1
Fmn
i (amn −αmn)
⎤
⎦
2
. (9)International Journal of Molecular Imaging 5
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Figure 4: One-tissue-compartment model used for quantifying
fatty acid metabolism during the ﬁrst 90s after injection of 123I-
BMIPP.
In general, the penalties (8)o r( 9)m a yb es c a l e d
by a smoothing parameter β. The penalized least-squares
criterion that we minimized for the work presented here is
Ψ2 =
I  
i=1
⎡
⎣p
∗
i −
M  
m=1
N  
n=1
Fmn
i amn
⎤
⎦
2
+β
I  
i=1
M  
m=1
N  
n=1
 
Fmn
i (amn −αmn)
 2,
(10)
where the ﬁrst term on the right-hand side is the least-
squares criterion (3) expressed in summation notation and
the second term is the scaled penalty (8). The criterion Ψ2 is
minimizedbythefollowingestimate,   a,ofc oeﬃcientsforthe
4-D B-spline basis functions that represent the time-varying
radiotracer distribution
  a =
  
1+βI
 
·FTF
 −1 
FTp
∗ +βdiag
 
FTF
 
·α
 
, (11)
where “1”i sa n( MN) × (MN)m a t r i xo fo n e s ,I is an
(MN) × (MN) identity matrix, “·” denotes the Hadamard
product (i.e., pointwise multiplication of elements in the
left operand by the corresponding elements in the right
operand), and diag(FTF)i sa n( MN)-element column vector
whose [m +( n − 1)M]th element is the [m +( n − 1)M]th
diagonal element of FTF.
Note that when the smoothing parameter β is zero, (11)
simpliﬁes to (4); whereas, the image estimate   a approaches
the smooth image prior α as β approaches inﬁnity. By virtue
of (6), a reasonable value is β = 1, which was used for the
work presented here.
2.5. Joint Estimation of Blood Input and Fatty Acid Metaboli-
sm. Toobtainaquantitativeestimateofthemetabolicrateof
123I-BMIPP in the myocardium, a one-tissue-compartment
model (Figure 4) is ﬁtted to TACs for higher-resolution
voxels in a 7 × 7 × 7 neighborhood centered on the blood
pool.Earlymyocardialtissueuptakeismodeledwithasingle,
irreversible compartment
tissue(t) = Ki ·
  t
0
blood(τ)dτ, (12)
where Ki is the metabolic rate of 123I-BMIPP. Each voxel
is modeled as a mixture of blood input and tissue uptake,
taking into account partial volume eﬀects
voxel(t) =
 
fv ·blood(t)
 
+
 
 
1 − fv
 
Ki ·
  t
0
blood(τ)dτ
 
,
(13)
where fv is the fraction of vasculature in the tissue and also
incorporates the eﬀect of spillover from the blood pool to
surrounding tissue voxels. For blood voxels, the factor (1 −
fv)Ki incorporates the eﬀect of spillover from surrounding
tissue voxels.
Because of tissue spillover, there is no reconstructed
voxel that contains a pure blood TAC; thus, the blood input
function is assumed to be unknown and is modeled by a B-
spline TAC
B(t) =
N  
n=1
bnVn(t). (14)
The temporal B-spline coeﬃcients {bn; n = 1,...,N}
are jointly estimated with compartmental model parameters
{(f m
v ,km); m ∈ Ω} for each voxel by minimizing the
following least-squares criterion:
 
m∈Ω
  T
0
 
  Am(t) −
 
f m
v B(t)+km
  t
0
B(τ)dτ
  2
dt, (15)
where Ω denotes the 7 × 7 × 7 neighborhood of voxels
centered on the blood pool, T = 90s, and km = (1− f m
v )Km
i .
Thus,thereisatotalof(2·73)+3= 689parameterstojointly
estimate (i.e., two compartmental model parameters f m
v and
km for each of the 343 voxels in the neighborhood Ω,a n d
three blood curve B-spline coeﬃcients b1, b2,a n db3).
The minimization proceeds by ﬁrst initializing B(t)t o
the TAC for the voxel at the center of the neighborhood Ω.
Then, optimal values for the B-spline coeﬃcients {bn; n =
1,...,N} for B(t) are found with use of an iterative
search algorithm. Note that one does not need to search
explicitly for optimal values for the conditionally linear
compartmental model parameters {(f m
v ,km); m ∈ Ω},a s
there are unique optimal values for these parameters given
B(t)[ 36, 37].
Values for Ki reported in the results are based on the ﬁnal
estimate for B(t) and the average of TACs for 12 myocardial
tissue voxels identiﬁed in static 3D images reconstructed
from summed late data acquired 1.5–60min after injection
(Figure 5).
3. Results
In the late 3D static images (Figure 5), more trapping of 123I-
BMIPP is evident in the WKY normal hearts (top two rows),
compared to the SHR hearts (bottom two rows). These static
images have been normalized to one another by normalizing
by the injected dose per unit body weight. Table 1 lists the
body weight of each rat for each study.
Fortheearly4-Ddynamicimages,theuseofnonuniform
time sampling with splines that varied quadratically in time,6 International Journal of Molecular Imaging
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Figure 5: Typically, more trapping of 123I-BMIPP is evident in late 3D static images of the WKY normal hearts (top two rows), compared
to the SHR hearts (bottom two rows). Trapping also tends to decrease with age (left column, 7 months; middle column, 14 months; right
column, 21 months). SHR B died of congestive heart failure before 21 months. These static images have been normalized to one another by
normalizing by the injected dose per unit body weight.
along with the use of a smooth 4-D image prior, yielded
smooth time-activity curves that captured the relatively fast
rise and fall of 123I-BMIPP in the left ventricular blood
pool, as well as the uptake and initial trapping of the
radiotracer in the left ventricular myocardium. Figure 6
shows time-activity curves for the spillover-corrected blood
input function and myocardial uptake (triangles and circles,
resp.), as well as the compartmental model ﬁt (solid line) to
the myocardial uptake curve, for each study.
The spillover of tissue activity into the left ventricular
blood pool averaged 19 ± 10% across all 11 studies.
Tissue spillover correction compensated for partial volume
eﬀects and improved the contrast between the blood input
and myocardial uptake curves for all studies and visuallyInternational Journal of Molecular Imaging 7
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Figure 6: Time-activity curves for the WKY normal rats (top two rows) and the SHRs (bottom two rows) capture quantitative diﬀerences
between their spillover-corrected blood inputs and myocardial uptakes (triangles and circles, resp.). Compartmental models (solid lines)
provide good ﬁts to the myocardial uptake curves. Left column, 7 months; middle column, 14 months; right column, 21 months. SHR B
died of congestive heart failure before 21 months.8 International Journal of Molecular Imaging
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(b) Result of tissue spillover correction
Figure 7: Time-activity curves for SHR A at 7 months estimated (a) without and (b) with tissue spillover correction for the blood curve.
Spillover correction improves contrast between the blood input and myocardial uptake (triangles and circles, resp.), improves the ﬁt of the
compartmental model (solid line), and yields a metabolic rate estimate (Ki) that nearly doubles, from 0.64min−1 to 1.12 min−1.
Table 1: Body weight of each rat for each study. SHR B died of
congestive heart failure before 21 months.
Body weight
7 Months 14 Months 21 Months
WKY normal A 420g 482g 545g
WKY normal B 432g 494g 564g
SHR A 430g 465g 416g
SHR B 403g 446g —
improved the ﬁt of the compartmental model for some
studies (Figure 7). Metabolic rate estimates (Ki) increased by
an average of 72 ± 45% across all 11 studies, compared to
estimates obtained without spillover correction.
Estimates of Ki obtained from corrected blood curves are
plotted as a function of age for all 11 studies in Figure 8.T h e
general decline with age is what one expects. Slower rates of
fatty acid metabolism in the SHRs at 14 months, compared
to the WKY normal rats, is also expected as the SHR hearts
switch to a reliance on glycolysis as the primary pathway for
energy production during the development of heart failure.
SHR B died of congestive heart failure before 21 months.
4. Discussion
We showed that it is potentially feasible to estimate the blood
and myocardial tissue time-activity curves in rat models
from projection measurements for dynamic data acquired
with slow camera rotation of 1s per projection, even when
recirculation times are on the order of 6–8s. The tissue
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Figure 8: Metabolic rate of 123I-BMIPP in the myocardium as a
function of age. SHR B died of congestive heart failure before 21
months.
spillover correction method compensated for partial volume
eﬀectsandr esult edinanincr easeof72±45%inestimatesof
metabolic rates Ki, compared to estimates obtained without
spillover correction. The results appear to indicate higher
fatty metabolism in the control WKY rats as compared with
SHRs. The fatty acid metabolic rate also decreases with age
in both animal models.International Journal of Molecular Imaging 9
T h er e v i e wo fN o h a r a[ 1] describes how BMIPP behaves
in normal and diseased hearts at the cellular and molecular
level. BMIPP is a 15-carbon chain with a methyl group
in the β-position which inhibits oxidative metabolism and
reduces myocardial washout kinetics. In the cell, 60% of
BMIPP will be retained mostly in the triglyceride (TG) pool
and has a longer retention than triglyceride, and 10% will
be more or less metabolized to be washed out of the cell.
Other than metabolizing to TG, the metabolites of 123I-
BMIPP are mostly intermediate or ﬁnal metabolites in the
mitochondria, where 123I-BMIPP is metabolized to p-123I-
iodophenyl acetic acid (PIPA) by alpha-oxidation as the
ﬁrst step, followed by a beta-oxidation process to lactate.
123I-BMIPP reﬂects fatty acid uptake and the size of the
lipid pool, and back diﬀusion of 123I-BMIPP and lactate
production are good markers of ischemia. A 10-fold increase
in the concentration of free fatty acid (FFA) in the blood
will decrease 123I-BMIPP extraction by 25% and increase
washout by 25%, whereas a 2-fold increase in the glucose
concentration in the blood does not inhibit 123I-BMIPP
uptake into the cell.
Lipid transport in the blood and in the cell is dependent
upon it being bound to proteins or lipid proteins such
as VLDL in the blood. Lipid is extracted into the cell by
membrane proteins and is aﬀected by albumin/FFA ratio
in the blood. Higher lipid or FFA/albumin level results in
greateruptakeoflipidintothecell.Fattyacidbindingprotein
(FABP) in the cytosole is one factor that regulates lipid
ﬂux. Lipid will be used either for oxidation, triglyceride or
phospholipidformation.Carnitinepalmityltransfereseisthe
key enzyme for the entrance of lipid into mitochondria, and
o x i d a t i v ee n z y m e ss u c ha sl o n gc h a i na c y lC o Ad e h y d r o g e -
nase(LCAD)willdeterminelipiduseintotheTCAcycle.The
eventual production of ATP in the mitochondria will limit
the size of TG storage. The several lipid enzymes in the cell
are regulated by nuclear genes that are individually activated
by peroxisome proliferator activated receptors (PPARs).
There are many endothelial proteins that are also involved in
the storage and metabolism of lipid. The amount of medium
chain acyl CoA dehydrogenase (MCAD) is closely related to
the progression of heart failure. In the compensated phase of
hypertrophy, m-RNA level of MCAD is reduced.
Even with species diﬀerences, our results (here for
fatty acid metabolism, and [6, 7] for glucose metabolism)
and other results obtained with the SHR model [38–40]
corroborate studies in humans, which show that there are
abnormalities in myocardial metabolic function manifested
by reduced rates of fatty acid utilization and oxidation
and an increase in glucose metabolism associated with
hypertension-induced left ventricular hypertrophy (LVH)
and idiopathic cardiomyopathy [21, 41]. In a separate
positron emission tomography (PET) study imaging 18F-
ﬂuorodeoxyglucose (FDG) with use of a microPET scanner,
we observed that glucose metabolism in the SHR model
was greater than that in the WKY control [6, 7], and that
the glucose metabolism in both decreased with age. Present
results diﬀer from results imaging fatty acid utilization in
patients with heart failure [13], where it was shown that
myocardial fatty acid uptake in patients with heart failure
was higher than that expected for the normal heart, whereas
myocardial glucose uptake rates were lower. It may be that in
the hypertrophied heart before heart failure there is greater
dependency on glucose and with eventual heart failure there
is a shift to fatty acid metabolism, and that this shift is an
indication of impaired energy eﬃciency in the failing heart.
Our work also corresponds to work by Okizaki et al. [5].
Using dynamic SPECT imaging of 123I-BMIPP, they showed
that fatty acid metabolism was higher in patients with hyper-
trophiccardiomyopathy.Usingmathematicalmodeling,they
showed that compartmental model rate parameters might
be a sensitive predictor for early detection of hypertrophic
cardiomyopathy and could be a useful index to evaluate
its progression. A two-compartment model was used where
the ﬁrst compartment was a reversible compartment (cyto-
plasma) and the second compartment (triglyceride pool)
was an irreversible compartment corresponding to the long
retention of BMIPP if incorporated into the triglyceride
pool. The compartmental analysis suggested that a fatty
acid shift (rate of transport into the TG pool higher than
normal and a decreased volume of distribution for the
ﬁrst compartment) from cytoplasm to the triglyceride pool
occurs in hypertrophic cardiomyopathy, even in the early
phase of the disease when no apparent change was observed
upon visual interpretation by nuclear medicine physicians.
B e c a u s eo ft h ec o m p u t a t i o n a ld e m a n d s ,w ew e r ea b l et o
model only the ﬁrst 90s of the kinetics in the myocardium.
We used a single, irreversible tissue compartment, and
therefore were able to measure only the uptake of 123I-
BMIPP, which we consider to be a measure of the metabolic
rate of 123I-BMIPP. It is anticipated that an additional,
reversible tissue compartment will be needed to account for
washout of 123I-BMIPP from the myocardium over longer
time scales.
123I-BMIPP imaging changes in the ischemic condition
[1]. Disparity between 123I-BMIPP uptake in the hypertro-
phied myocardium and delayed 201Tl redistribution images
in rest/stress studies indicate that myocardial ischemia plays
an important role in impaired fatty acid utilization and
metabolism in hypertrophied myocardium [4]. Myocardial
ischemia is present with hypertrophic cardiomyopathy for
several reasons: small coronary artery disease, coronary
artery spasms, left coronary artery compression, inadequate
capillary density in relation to the increased myocardial
mass, and impaired coronary ﬂow reserve. Lipid metabolic
regulation completely diﬀe r sf r o mn o r m a li nt h ev e r ye a r l y
phase of cardiac hypertrophy and with deteriorating heart
failure, and metabolic switching from lipid to glucose will
occur [1]. A slight reduction in ﬂow will be reﬂected in
an increase in glucose metabolism to a level 4-5 times
the resting value, but the lipid metabolism will remain
constant [1]. At less than 40% of resting ﬂow, both lipid and
glucose metabolisms decrease remarkably [1]. Extraction of
lipids will decrease in cases of prolonged ischemia [1]. The
myocardial accumulation of 123I-BMIPP is also related to
ATP content, and thus may reﬂect pO2 levels [4]. Decreased
myocardial 123I-BMIPP uptake in areas of stress-induced
ischemia on 201Tl imaging indicated that exercised-induced
metabolic changes persisted even in the resting condition10 International Journal of Molecular Imaging
[4]. The possibility of an unknown hereditary fatty acid
metabolic abnormality that could account for reduced 123I-
BMIPP accumulation in hypertrophic cardiomyopathy has
also been reported [4].
Our studies show a decrease in fatty acid metabolism in
boththeSHRandWKYratwithage.Inonestudyinhumans
itwasobservedthatmyocardialfattyacidutilization(MFAU)
and myocardial fatty acid oxidation (MFAO) declined with
age while myocardial glucose utilization (MGU) did not
change; thus, the proportional contribution of glucose used
to overall substrate utilization relative to fatty acids was
increased [42]. The decline in MFAO and MFAU with age
may reﬂect a decline in mitochondrial long-chain fatty acid
uptake [43], and alterations in mitochondrial lipid content,
composition, and protein interactions, leading to signiﬁ-
cant membrane dysfunction [44]a n de ﬀects of impaired
myocardial vasodilator capacity [45]. The study in humans
[42] appears to correlate with some studies in mouse and
rat experimental models that show that the contribution of
MFAO to overall myocardial substrate metabolism declines
with age, and that the proportion of glucose metabolism
to overall substrate metabolism increases [46]. However,
one study in rats [47] appears to contradict these results
showing that during the transition from adulthood to
senescence, there is an increase in palmitate (fatty acid)
oxidation and a decrease in lactate oxidation, and that this is
associated with signiﬁcant deterioration in cardiac function
andeﬃciency.Thispapersuggeststhatthemetabolicchanges
occur in parallel with hypertrophy. Thus, if hypertrophy is
involved there could be an accompanied disproportionate
enlargement in cell length causing an increase in the cell
length-to-width ratio [48]. Cell loss, which increases with
age [49], may also play an increasing role in the transition to
heart failure by placing a greater workload on the remaining
viable cells. The detrimental eﬀect of increased fatty acid
utilization observed in the senescent heart may be attributed
to the fact that fatty acids are a less eﬃcient fuel in terms of
myocardial oxygen consumption (MVO2) [50].
Limitations of our present study are (1) small sample
size (two WKY, two SHR), (2) animals were not fasted,
(3) no blood pressure data, (4) no independent validation
of the input function either from blood samples or from
simulation, (5) data were not corrected for attenuation or
scatter, and (6) only the ﬁrst 90s of the dynamic data were
processed. Regarding fasting, it was felt that the animals had
fairly similar free fatty acid, insulin, and glucose levels, which
we veriﬁed in another study in which we sampled blood.
Blood pressure is very diﬃcult to obtain in these animals.
Presently, simulations with known blood input functions are
underway to determine the bias and variance that one would
obtain with the experimental data. In future studies we plan
to implement attenuation and scatter correction using the
transmission source on the GE Hawkeye SPECT/CT system.
Wehaveperformedsimulationsthatshowedimprovementin
quantitationusingscatterandattenuationcorrection[35].In
a rat it improves quantitation by 10–15%. Future work will
also include addressing computational issues associated with
reconstructing a 4-D dynamic image from the entire 60min
of projection data.
Our injected dose of 4mCi (150MBq) is high when
compared with dose/weight ratios of what one would give a
human. The injected dose was based on our past experience
[8,9]astowhatweanticipatedthephotoncountingstatistics
needed to be to perform the data analysis. Our statistical
uncertainties appear to be reasonable. Nonetheless, this still
needs to be evaluated in an extensive study of statistical
precision based on injected dose in rats. We have not found
any harmful eﬀects to the animals using this dose; however,
an extensive radiobiology study has not been performed.
The work presented here relates primarily to the devel-
opment of technology for dynamic pinhole SPECT imaging
of small animals. The results are the ﬁrst to report on being
able to measure fatty acid metabolic rate in rats with use
of a clinical pinhole SPECT system with slowly-rotating
detectors. From a technical standpoint, this measurement
wasmadepossibleinpartbecauseoftheslow(10–30s)injec-
tion of 123I-BMIPP, which allowed good angular sampling
of the projections of the blood input function. The slow
injection was also necessary, so as not to overwhelm the rat’s
circulatorysystemwiththeadditionalvolume(∼1mL)ofthe
injectate.Forfasterinjectionsofsmallervolumesofinjectate,
an imaging system with stationary detectors, such as the
U-SPECT II preclinical scanner [51], is better-suited for
tomographic imaging of the resulting faster kinetics. The U-
SPECT II also has the advantage of having a collimator with
75 1-mm pinholes for use with imaging rats, which provides
about 13 times the sensitivity of our two-pinhole system and
the ability to resolve 0.8-mm “cold” rods in a radioactive
background [51]. Sensitivity and spatial resolution of our
system could also be improved by judiciously increasing the
number of and decreasing the size of the pinholes.
Our methods can also be applied to other imaging
modalities, such as dynamic PET. We are presently studying
fatty acid metabolism as a function of age in SHR and
WKY rats using microPET imaging of the fatty acid analog,
14(R,S)-[18F]ﬂuoro-6-thia-heptadecanoic acid (18F-FTHA)
[52]. Combining new dynamic and conventional clinical
imaging protocols with improved descriptions of the heart
(physiological, mechanical, and biochemical) will allow
better speciﬁcation of the heart’s properties. This, in turn,
will facilitate the study of how these properties are aﬀected
by molecular changes in the heart caused by disease.
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